Our programme brings together research from five principal co-investigators studying deregulated metabolism in the context of obesity and obesity-related metabolic disorders such as Type 2 Diabetes, metabolic dysfunction-associated steatotic liver disease (MASLD), cardiovascular disease, and cancer.